Source: International Congress 2019 – Biology and prognosis of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Sotiropoulos (Athens, Greece), G. Christodoulatos (Athens, Greece), I. Karampela (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), M. Kotopouli (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Lekka (Athens, Greece), A. Papavassiliou (Athens, Greece), M. Dalamaga (Athens, Greece). Classic and Novel Adipokines as diagnostic biomarkers in NSCLC. 3057

Member's Comments

No comment yet.

Related content which might interest you: Chemerin and PAI-1 activity as diagnostic biomarkers in resectable NSCLC:comparison to classic tumour markers Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Proteases as tools for diagnosis and novel therapeutics Source: ERS Research Seminar 2015 Year: 2015 Non invasive biomarkers in the diagnostic and prognostic evaluation of Pulmonary Fibrosis Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Are serum leptin levels a prognostic factor in advanced lung cancer? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Childhood allergies and obesity relationship: Identification of novel non-invasive biomarkers Source: International Congress 2019 – Asthma and the world Year: 2019 Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 Evaluating the utility of mesothelin in diagnosing mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Common therapeutic approaches in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 Lung cancer biomarkers based on miRNA Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 Biomarkers Source: Eur Respir Monogr 2013; 62: 90-95 Year: 2013